{"id":"https://openalex.org/W1995443607","doi":"https://doi.org/10.1007/s40259-013-0020-y","title":"Development and Regulation of Biosimilars: Current Status and Future Challenges","display_name":"Development and Regulation of Biosimilars: Current Status and Future Challenges","alternate_titles":[],"publication_year":2013,"publication_date":"2013-04-03","ids":{"openalex":"https://openalex.org/W1995443607","doi":"https://doi.org/10.1007/s40259-013-0020-y","mag":"1995443607","pmid":"https://pubmed.ncbi.nlm.nih.gov/23553340"},"language":"en","primary_location":{"id":"doi:10.1007/s40259-013-0020-y","doi":"https://doi.org/10.1007/s40259-013-0020-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40259-013-0020-y","pdf_url":null,"source":{"id":"https://openalex.org/S143194599","display_name":"BioDrugs","issn_l":"1172-7039","issn":["1172-7039","1173-8804","1179-190X","2195-8351"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1995443607"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089327230","display_name":"Asterios S. Tsiftsoglou","orcid":"https://orcid.org/0000-0002-4681-6617","observed_orcids":["https://orcid.org/0000-0002-4681-6617"]},"institutions":[{"id":"https://openalex.org/I21370196","display_name":"Aristotle University of Thessaloniki","ror":"https://ror.org/02j61yw88","country_code":"GR","type":"education","lineage":["https://openalex.org/I21370196"]}],"countries":["GR"],"is_corresponding":true,"raw_author_name":"Asterios S. Tsiftsoglou","raw_affiliation_strings":["Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. tsif@pharm.auth.gr","Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. tsif@pharm.auth.gr","institution_ids":["https://openalex.org/I21370196"]},{"raw_affiliation_string":"Laboratory of Pharmacology, Department of Pharmaceutical Sciences, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece","institution_ids":["https://openalex.org/I21370196"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027761068","display_name":"Sol Ruiz","orcid":"https://orcid.org/0000-0002-2937-0916","observed_orcids":["https://orcid.org/0000-0002-2937-0916"]},"institutions":[{"id":"https://openalex.org/I4210142787","display_name":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","ror":"https://ror.org/043fs9135","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210098440","https://openalex.org/I4210142787"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Sol Ruiz","raw_affiliation_strings":["Spanish Medicines Agency (AEMPS), Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Spanish Medicines Agency (AEMPS), Madrid, Spain","institution_ids":["https://openalex.org/I4210142787"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103216709","display_name":"Christian K. Schneider","orcid":"https://orcid.org/0000-0002-6691-0045","observed_orcids":["https://orcid.org/0000-0002-6691-0045"]},"institutions":[{"id":"https://openalex.org/I231211053","display_name":"National Board of Health","ror":"https://ror.org/04r17y386","country_code":"DK","type":"government","lineage":["https://openalex.org/I231211053","https://openalex.org/I4210164998"]},{"id":"https://openalex.org/I4210151865","display_name":"Center for Experimental and Clinical Infection Research","ror":"https://ror.org/04bya8j72","country_code":"DE","type":"facility","lineage":["https://openalex.org/I1305996414","https://openalex.org/I34809795","https://openalex.org/I4210124929","https://openalex.org/I4210151865"]}],"countries":["DE","DK"],"is_corresponding":false,"raw_author_name":"Christian K. Schneider","raw_affiliation_strings":["Danish National Health and Medicines Authority, Copenhagen, Denmark","Twincore Center for Infection Research, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Danish National Health and Medicines Authority, Copenhagen, Denmark","institution_ids":["https://openalex.org/I231211053"]},{"raw_affiliation_string":"Twincore Center for Infection Research, Hannover, Germany","institution_ids":["https://openalex.org/I4210151865"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5089327230"],"corresponding_institution_ids":["https://openalex.org/I21370196"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":null,"fwci":6.0158,"has_fulltext":false,"cited_by_count":117,"citation_normalized_percentile":{"value":0.97172122,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"27","issue":"3","first_page":"203","last_page":"211"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":1.0},{"id":"https://openalex.org/keywords/biopharmaceutical-regulation","display_name":"biopharmaceutical regulation","score":0.8289999961853027},{"id":"https://openalex.org/keywords/drug-approval","display_name":"drug approval","score":0.7649999856948853},{"id":"https://openalex.org/keywords/non-functional-requirements","display_name":"non-functional requirements","score":0.7099999785423279},{"id":"https://openalex.org/keywords/eu-regulatory-framework","display_name":"EU regulatory framework","score":0.6430000066757202},{"id":"https://openalex.org/keywords/european-medicines-agency","display_name":"European Medicines Agency","score":0.6669999957084656},{"id":"https://openalex.org/keywords/manufacturing-variability","display_name":"manufacturing variability","score":0.5239999890327454},{"id":"https://openalex.org/keywords/patent-expiration","display_name":"patent expiry","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.9857176542282104},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.7392513155937195},{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.5739505887031555},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.5730380415916443},{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.5596623420715332},{"id":"https://openalex.org/C2779606619","wikidata":"https://www.wikidata.org/wiki/Q17092524","display_name":"Interchangeability","level":2,"score":0.5300058126449585},{"id":"https://openalex.org/C2910001868","wikidata":"https://www.wikidata.org/wiki/Q458","display_name":"European union","level":2,"score":0.527574896812439},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.5244303345680237},{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.4323309063911438},{"id":"https://openalex.org/C91306197","wikidata":"https://www.wikidata.org/wiki/Q45767","display_name":"Competition (biology)","level":2,"score":0.42033979296684265},{"id":"https://openalex.org/C2779962950","wikidata":"https://www.wikidata.org/wiki/Q5659376","display_name":"Harmonization","level":2,"score":0.4120980203151703},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3755747377872467},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.35272789001464844},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.23898077011108398},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.1638883352279663},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.14163199067115784},{"id":"https://openalex.org/C155202549","wikidata":"https://www.wikidata.org/wiki/Q178803","display_name":"International trade","level":1,"score":0.13653242588043213},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13076311349868774},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C84309077","wikidata":"https://www.wikidata.org/wiki/Q3908516","display_name":"Entrepreneurship","level":2,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005062","descriptor_name":"European Union","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007880","descriptor_name":"Legislation, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057915","descriptor_name":"Drug Substitution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s40259-013-0020-y","doi":"https://doi.org/10.1007/s40259-013-0020-y","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s40259-013-0020-y","pdf_url":null,"source":{"id":"https://openalex.org/S143194599","display_name":"BioDrugs","issn_l":"1172-7039","issn":["1172-7039","1173-8804","1179-190X","2195-8351"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs","raw_type":"journal-article"},{"id":"pmid:23553340","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23553340","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.4043000042438507}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1540299321","https://openalex.org/W1590801360","https://openalex.org/W1706722196","https://openalex.org/W1982500058","https://openalex.org/W2006866083","https://openalex.org/W2029866871","https://openalex.org/W2038017739","https://openalex.org/W2056045216","https://openalex.org/W2067616183","https://openalex.org/W2081306620","https://openalex.org/W2088570089","https://openalex.org/W2102907120","https://openalex.org/W2111286621","https://openalex.org/W2115705858","https://openalex.org/W2163758618","https://openalex.org/W4213148426"],"related_works":["https://openalex.org/W2328313174","https://openalex.org/W2331507278","https://openalex.org/W2971993847","https://openalex.org/W7221366417","https://openalex.org/W2566622391","https://openalex.org/W2014310091","https://openalex.org/W7201873404","https://openalex.org/W2065652260","https://openalex.org/W2027316720","https://openalex.org/W7218200820"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1995443607","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":11},{"year":2017,"cited_by_count":15},{"year":2016,"cited_by_count":11},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2016-06-24T00:00:00"}
